Connect with us


5 Takeaways from Colorado’s Proposition 122 – The Natural Medicine Health Act




Article by: Partner Jeff Zuber, Counsel Raza Lawrence, and Associate Lizzie Fanckboner.

In November 2022, Colorado voters passed Proposition 122, the Natural Medicine Health Act (NMHA), which establishes a regulated natural medicine access program and provisions for personal use of natural medicines. Under this new law, Colorado will become the second US state – following Oregon – to issue licenses allowing the commercial production and administration of federally-illegal psychedelic substances.  The state-licensed psychedelic programs follow in the footsteps of cannabis state legalization initiatives adopted by states across the country that, like the psychedelic measures, license and regulate conduct under state law that constitutes a crime under the federal Controlled Substances Act.

  1. Regulated Psilocybin Program in Colorado

Just like Oregon’s psilocybin licensing program, Colorado’s state-regulated program will provide participants with access to natural psychedelic substances under the supervision of a licensed facilitator. The NMHA tasks Colorado’s Department of Regulatory Agencies (DORA) with overseeing and adopting rules to govern the natural medicine access program, taking guidance from the Natural Medicine Advisory Board’s recommendations. There are two initial license types contemplated by the statute – Licensed Healing Centers and Licensed Facilitators – but additional licenses and registrations may be created by DORA.

Although Colorado’s NMHA uses words typically associated with the medical and pharmaceutical industries – “medicine,” “health,” “treatment,” “recovery,” and “healing” – it does not contemplate any involvement of medical doctors.  Instead, Colorado’s law – like Oregon’s– will allow all people 21 years of age or older to purchase and use psychedelics, without the recommendation or approval of any doctor or other health care professional.

Colorado’s program will start with psilocybin and psilocin, but may be expanded after June 1, 2026 to include one or more of the other substances identified in the definition of “natural medicine”: DMT, ibogaine, and mescaline (but not mescaline extracted from peyote).

The definition of a “healing center”is broad and purposefully flexible.






There is a lot to unpack here, but suffice it to say, psychedelics can potentially be cultivated, sold, and consumed at any of a wide variety of locations under this definition.  The NMHA also directs DORA to establish rules that will allow for psychedelics to be administered in “another location” that is not a designated healing center, “as permitted by rules adopted by the Department.”  Such locations could potentially include private residences, other types of health-care facilities, and outdoor natural settings. With that said, we will see how the framework and boundaries take shape with the creation of the rules, which are scheduled to be adopted in 2024.

There will be training programs for facilitators and certain education and qualification requirements. Licensing for facilitators will be tiered, so as to provide for varying levels of education and training depending on the participants the facilitator will be working with and the services.

  1. Personal Use Now

Part of the NMHA removed criminal penalties for the personal use of natural medicine for persons 21 years of age or older. The personal use section is separate from the regulated natural medicine access program in the NMHA. Think of the NMHA as having two parts – one is the regulated natural medicine program and the provision of natural medicine services; and the other is personal use. The personal use provisions allow for the cultivation, processing, storing, using, transporting, obtaining and ingesting of natural medicines, including dimethyltryptamine (DMT), ibogaine, mescaline (not from peyote), psilocybin and psilocyn, for personal use. There are some boundaries to this personal-use decriminalization written into the NMHA, which are summarized below.

– Retail sales are prohibited. There is no retail market provided for, or intended by the NHMA, outside of what is allowed in the context of licensed healing centers. Outside of the licensed healing centers, a person may still charge for bona fide therapy or harm reduction services, or other support services with a connection to natural medicine, but there can be no remuneration for the natural medicine.

– Personal use is not allowed for those under the age of 21. A person who is under 21 year of age will be subject to a drug petty offense for possession, use, transporting, sharing, natural medicine or natural medicine paraphernalia, subject only to a penalty of more than four hours of drug education or counseling provided at no cost to the person.

– There is no cultivation or consumption permitted in schools, detention centers, public spaces or federal lands. Keep in mind that the natural medicines under NMHA are still schedule I substances, and are still federally illegal.

– People are not allowed to give away any amount of natural medicine as part of a business promotion or other commercial activity,

– People are not allowed “to permit paid advertising related to natural medicine, sharing of natural medicine, or services intended to be used concurrently with a person’s consumption of natural medicine.”  It is unclear how, or whether, this provision would apply to any advertising done in connection with licensed psilocybin healing centers.

The takeaway here is that the intent for personal use under the NMHA is to provide individuals with additional options for their mental health and spiritual growth, and to remove penalties associated with indigenous and traditional uses.

In practice, most people who use psychedelic substances acquire them from other people, whether or not any compensation exchanges hands.  Outside the context of licensed healing centers, any such transactions will continue to be prohibited, although the decriminalization of personal possession and use will likely result in fewer overall prosecutions, and a de-emphasis on prosecution of lower-level transactions.

  1. Colorado’s NMHA differs in notable respects from Oregon’s Psilocybin Services Act

There are several differences between Colorado’s NMHA and Oregon’s Psilocybin Services Act. A few salient points of comparison are outlined below.

Under Oregon’s Psilocybin Services Act, psilocybin may only be administered in licensed service centers. The effect is that the number of service centers will be limited and that limitation in turn reduces options and may increase costs. On the other hand, Colorado’s NHMA allows for the provision of psilocybin services outside of licensed healing centers and specifically contemplates natural medicine services being provided in places such a residential homes, community mental health centers, long-term care facilities, or other types of facilities where health care is provided. There is purposeful flexibility worked into the NMHA with regard to where natural medicine services may be provided. As the regulations are being developed, we will see exactly how this will look, but the hope is to create opportunities for equitable access to natural medicines.

Another difference is that Colorado does not have a residency requirement  written into the NMHA. We previously wrote about Oregon’s requirement that psilocybin businesses be majority-owned by Oregon residents here.

Oregon’s psychedelics program is limited to the licensing and regulation of psilocybin activities.  Colorado’s program, however, expressly contemplates extending the licensing program to cover the distribution and administration of three other psychedelic substances: DMT, ibogaine, and certain forms of mescaline.

Colorado’s NMHA contemplates that licensed healing centers will be allowed to cultivate and manufacture psychedelic substances in addition to administering them to adults.  Oregon, by contrast, has separate license types for psilocybin manufacturers and psilocybin service centers, contemplating that many businesses may focus on either manufacturing or administration, and will not be a single vertically-integrated organization.

Colorado’s NMHA decriminalizes the personal possession and use of various psychedelic substances, while Oregon’s psilocybin licensing program did not address personal use of psilocybin outside the context of licensed service centers.  Oregon, however, passed a law in November 2020 (Measure 110) decriminalizing the possession for personal use of small amounts of all controlled substances, making such conduct civil infractions punishable only by citation and a $100 fine (which can be waived by calling a hotline to screen for substance use disorder).

Finally, the Oregon Psilocybin Services Act provided an out for local jurisdictions whose residents did not want to participate in the program. As such, many cities and counties opted out of the program in this past November’s election. Conversely, under Colorado’s NMHA, a local jurisdiction may not completely prohibit the establishment or operation of a healing center. Localities can, however, enact reasonable ordinances and regulations so long as they do not conflict with NMHA, and thus will have the practical ability to make it difficult for psychedelic businesses to operate.These are just a few points and only skim the surface in the comparison of the two programs. As Colorado gets moving on discussing the regulations, we will see start to see the program take shape.

  1. Will it be like the cannabis industry?

Yes and no.

While both industries contemplate a state-regulated program or industry that is illegal under federal law, one major difference is that the NMHA is not intended to create an open retail market like we are all familiar with in the cannabis industry. The intention of the NMHA is to create a program for the supervised use of natural medicines, starting with psilocybin or psilocin, but the NMHA does not contemplate a dispensary model, or retail sales outside the context of supervised use.

On the similarity side, interested parties hoping to enter this new ecosystem of natural medicine and natural medicine services will face barriers similar to those that the cannabis industry confronted. The common denominator between the two industries is the fact that cannabis and psilocybin are both listed on schedule I of the federal Controlled Substances Act. Therefore, psilocybin businesses will face issues with taxes (280E), access to banking (or lack thereof), buying or leasing property for the business (cost, lease agreements, etc.), obtaining insurance, and securing federal trademark protection.  As with cannabis businesses, absent a change in federal law, everyone participating in Colorado’s licensed psychedelic industry will also face the continuous threat of federal criminal prosecution and asset forfeiture, even if operating in full compliance with state laws.

  1. What is coming up?

The first date to keep in mind is January 31st. By then, the Governor of Colorado will have hopefully appointed the members of the Natural Medicine Advisory Board, who will be drafting recommendations for the regulations, to provide to DORA.

Next, by September 2023, we will hopefully see recommendations from the Natural Medicine Advisory Board for DORA’s eventual rules, as well as recommendations related to research, training, product safety, harm reduction, cultural responsibility, and requirements to ensure that the regulated natural medicine access program is equitable and inclusive, just to name a few.

Then, by a year from now, DORA is expected to adopt rules that establish the qualifications, education, and training requirements that facilitators must meet before providing natural medicine services and to approve any required training programs.

Finally, by September 30, 2024, the rules governing the program should be adopted and DORA will open its doors to accepting applications, which by law are to be processed and approved or rejected within 60 days of submission.

In the meantime, interested parties can participate in the rulemaking process, work on developing a corporate structure and business plan, engage with local officials and community groups regarding zoning and other local considerations that may impact psychedelic businesses, and start discussions with their CPA or accountant on a tax strategy.


Source link

Continue Reading

blue lotus

Blue Lotus & The US Military: Is It A Problem?




Entheogenic plants are on the rise! And a new one to US consumers, blue lotus; is already getting attention from the US military.

What’s blue lotus?

Blue lotus, which goes by the official name of Nymphaea caerulea, is a type of water lily. For this reason, it’s also known as ‘blue water lily.’ It lives in fresh water environments, and is found often in East Africa, and Southern Arabia. It’s considered an ornamental plant, and has spread to different parts of the world through trade.

The plant has the ability to grow in mud that lacks both nutrients and oxygen; and has flowers that open in the morning, and close in the afternoon. The flowers can range from blue to white to mauve to pink. It should not be confused with its cousin plant, N. Lotus, which is known for its white flowers, or N. Mexicana which generally has yellow flowers. These are both found mainly in South Africa.

The plant was used through history, with many mentions from Ancient Egypt; where it shows up in writings like the Book of the Dead, and the Ebers Papyrus from 1,5000 BC. It’s thought the Turin Papyrus references it as well. These document its uses as a spiritual enhancer, as well as a medicine for tons of ailments. Egyptians considered it a symbol of life and immortality; and it was used to communicate with the divine; and to help navigate entrance into the afterlife. It’s associated with euphoria and at times hallucinations; and the flower shows up commonly in Egyptian art.

Egyptian art showing blue lotus
Egyptian art showing blue lotus

The main psychoactive compound is apomorphine, while other compounds are thought to contribute, like nuciferine. It’s been used historically as a medical agent for things like: sex drive enhancement, pain, depression, anxiety, insomnia, and upset stomachs. Apomorphine is associated with improvement in Alzheimer’s symptoms, as well as with erectile dysfunction.

It’s also associated with being an edible plant in South Africa, from which the rootstock was eaten by local communities. While this practice is said to date back to at least 1800, the logic answer is that it likely went on for hundreds, or even thousands of years, prior. Its said this is no longer a custom anymore. When it was eaten; this was done raw, or the plant was used to make curry.

Lotus flowers are aromatic, and were used to create perfume in ancient times. They are still used in aromatherapy today. It seems some amount of knowledge of the plant must have surfaced around 2009, as that year it was banned or restricted in Latvia, Poland, and Russia. Always an odd move when a plant has been around and used, for so much of history.

Blue lotus and the US military

These days, blue lotus is generally vaped. It’s not a scheduled drug in America, so its not illegal to possess or use; but its also not well known about yet, so there aren’t any well-known providers. It can be purchased in America in ‘smart shops,’ which specialize in the sale of psychedelics, entactogens, and other hallucinogens; but is more likely found in online marketplaces.

Blue lotus received attention in recent years due to several cases involving US soldiers. Although having said this, ‘several cases’ amounts to just a few cases, with no death involved. The cases were put together into a study, which came out in 2021. It is not specified why any of the involved, used the plant.

The study in question is called Toxicity From Blue Lotus (Nymphaea caerulea) After Ingestion or Inhalation: A Case Series. It consists of case material related to five military soldiers in active duty, who ended up in an emergency room due to altered mental states. Four of the soldiers had vaped a blue lotus product, while the last drank an infused drink.

Study on soldiers and blue lotus
Study on soldiers and blue lotus

All the soldiers presented with strange behavior, as well as a disturbance in general perception. Anxiety was also frequently seen. One soldier, age 27, was brought in by emergency medical services when his friends found him leaning against a wall, and staring into nothing. He reportedly had been found in this state, several times within the weeks prior. This soldier had ordered a vape liquid said to contain blue lotus through an internet site, but wouldn’t give much more information. Within a few hours, he was back to normal.

Another soldier, age 29, was brought in by emergency services for low responsiveness. This patient also reported vaping the substance. His family noted to EMS services that they believed he had been hallucinating, and had shown other strange behaviors. Like the first case, the symptoms resolved within hours. In fact, by the time EMS services arrived, he was already doing much better, and didn’t have to be held for more than four hours.

The third was a 22-year old soldier who was reported to have been engaging in bizarre behavior; which included sitting on a fence when he was found. The soldier reported drinking a wine that was infused with blue lotus flower; something he bought from eBay. Like the first two, his symptoms didn’t last long enough to be held past 2 hours, 45 minutes; and he was given no treatment.

The fourth example was a 19-year old soldier who came into the emergency room with chest pains. He reported that his pain began three hours prior to arrival, and that he had taken four hits from a vape, which he said was spiked. The vape came from the soldier’s friend, and there was an assumption it contained blue lotus. The pain went away quickly enough that he was released less than four hours after arrival. Like all the other cases, there was no confirmation of whether it was indeed blue lotus or not.

The last case was a 20-year old soldier who ended up in the emergency room because of bizarre behavior. He took a hit off a vape containing blue lotus, and proceeded with “thrashing his extremities;” I assume wildly enough for people to be concerned. He is the only one of the five to receive any actual treatment, which was simply fluids given intravenously. His vital signs returned to normal within three hours, and he requested to go, prior to a re-evaluation. A subsequent doctor’s visit showed metabolic normalcy.

The main takeaway points of this study

There are a few things to take out of this study, even though it was very small scale. The first is that blue lotus does not seem deadly. These are the only five cases spoken about related to the military. If there are more, they weren’t mentioned, which implies probably not. If these are indeed the worst case scenarios, then this study speaks to the general safety of the drug. These cases, perhaps, stand as examples of extreme scenarios; the kind that can happen with anything.

Buyers should be careful with online drug marketplaces
Buyers should be careful with online drug marketplaces

The next thing to understand, which is very important; is that blue lotus was not confirmed in any of these cases, and the products all (or nearly all) came from internet vendors. We could very well be looking at a study of five men, who all had issues unrelated to blue lotus, but who all thought they ingested it. Given that these came from internet purchases, and it doesn’t sound like any of the material was tested; we actually have no formal idea of what happened to these men. It’s quite possible they responded to additives, or that the products were not blue lotus at all.

This study makes clear two ting; how shady a lot of internet providers can be, and how important it is to understand dosing of a compound. It could be that all the products were what they were sold to be, and that the blue lotus did this. Or, it could be that none of the products were sold as what they were advertised to be. This might be less about blue lotus, and more about internet providers who want to make a buck. But it could also be that the men ingested far more than they should have.

Overall, assuming these were blue lotus cases, one of the biggest takeaways, is that its not terribly different from a THC overdose, or a bad trip on psychedelics. A person will feel very bad, and act in strange ways; but they’re also likely to settle back down within hours, and then be fine. In fact, this entire study does little to indicate this is a plant of concern to health and well-being; while its history shows it to be a useful medicine.


There doesn’t seem to be a reason for concern over blue lotus. This isn’t to say it can’t cause problems when taken in high amounts, when cut with additives, or when fake products are sold under its name. But there aren’t reports of death, and few of toxicity. Between these two factors, it presents, as yet, another useful plant (when used properly), which doesn’t deserve to have fear attached.

Welcome all! We appreciate you joining us at; your #1 choice for drug-related independent news focused on cannabis and hallucinogens. We provide regular updates so come around regularly; and sign up to our Cannadelics Weekly Newsletter; so you’re always on top of what’s going on.

Source link

Continue Reading


Drug Plants Vs Manufactured Products: What’s Better?




When it comes to plant drugs, you often have the option of the plant, or manufactured products. Which is better? Read on…

Plant drugs

Not every drug is a plant. Though some like LSD and MDMA are based on plants or are synthesized using plants (ergot fungus and sassafras, respectively), some popular drugs, are nothing but a plant. Think of weed. We call it by this word because it’s literally a weed that grows by roadsides in many places. It doesn’t require any preparation beyond heating it; and plenty is gained without heat at all. Magic mushrooms are another great example of a basic plant drug that can be pulled from the ground and ingested, with no further preparation.

Beyond this, we have a range of drugs that started as natural, but were then processed into something stronger. Like heroin. Heroin is morphine processed with ascetic acid. Or cocaine, a processed form of coca leaves that involves nitric acid. In these cases there’s a certain amount of processing that goes on, but its done around the basis of the original plant. However, due to the processing; the results are a much more intense product. Cocaine is even processed further to make crack, a more intense version of cocaine.

Plant drugs have been used for thousands of years, long past recorded history. Some of what we know comes from fossilized findings, and carbon dated remnants. In terms of recorded history, from medical books to scripture; plants factor in as far as recordings go back. Different locations of the world worked with what they each had available. And they often came to the exact same understandings of a plant, in differing periods and locations; for which there would have been no communication or ways to share ideas.

Lab-made cannabis products
Lab-made cannabis products

Plants were (and are) widely used for spiritual purposes by many indigenous tribes the world over; as well as for medical treatments, and recreational use. Sometimes they are used so much, and so entrenched in culture; that modern governments allow them. Peyote is a great example. It’s used so widely by native cultures in the US, the federal government finally legalized the plant for spiritual use; a law that applies to anyone who wants to use the plant for this purpose, even beyond native tribes.

Synthetic drugs

The other side in plants vs manufactured products, is the manufactured products. These fall into two categories in my mind: products that are made from a plant, but produced in a different form; or completely synthesized, lab-made drugs. In either case, these products don’t grow directly out of the ground.

When it comes to products made from the plant, without creating a new drug; one of the best examples is vape products for cannabis and tobacco. And by this I specifically mean oil vapes, since dry herb vapes don’t require any level of production for the weed used. Oil vapes are vapes that use oil cartridges, and these cartridges contain compounds from the plants, that are leached into the oil. Instead of dealing with the plant, the user just deals with an oil cartridge and a battery.

Edible products are also included here. A brownie is not directly weed, and a gummy is not directly a mushroom. The drugs must be processed to some degree to create an edible form. This is something the average person can do in their kitchen with the right setup; but something for which there is a large and growing sales market, as well. Whereas you can choose what to put in when cooking at home; store-bought products include whatever ingredients the given company chose for their recipe.

When it comes to synthesized lab-made drugs, some examples are drugs like LSD, MDMA, antidepressants, synthetic opioids, Tylenol, and methamphetamine. There is no original form of any of these, so the only way they exist, is as lab-made products. Whether they’re synthesized using a plant is not important; as the drugs themselves are too different from the plants that they’re made from, to be associated with them in terms of effects.

Plants vs manufactured products – when manufactured is better

Some drugs only exist as one or the other. There is no natural form of methamphetamine, but there is also no lab-made version of salvia. Others exist in both realms. You can eat amanita mushrooms, or buy the gummy version; and same with cannabis. Both of these plants, and their accompanying industries, are great examples of the difference between plants and manufactured products.

Amanita mushrooms are an example of plant drugs
Amanita mushrooms are an example of plant drugs

Which is better? This is a matter of opinion. When it comes to weed, some manufactured products, like vapes, provide a more intense high than the plant itself; because they’re a more concentrated version. This is a useful concept for medicating; when often a very strong version of something is needed to get a medical effect. The weed industry provides both options, plants and manufactured products; and either can be decent in terms of effects, with manufactured products often offering a more intense experience.

Amanita mushrooms are another plant drug that has a good reason for manufacturing. These mushrooms come with a main compound that can make a person sick; though not enough to die. This compound, ibotenic acid, can be processed out through the decarboxylation method of boiling. This can be done by the individual who wants to use them; or by manufacturers who produce gummies or other edible products. In the latter case, all the user must do, is eat the product.

Manufactured products also come with the upside of dosing. We don’t all want or need the same amount, but its hard to know how much of the active compounds (or dangerous compounds) we’re taking in, when consuming plant material. Manufactured products generally have measured levels of compounds, creating a consistent experience; and making it easier for those who are less familiar with something, to get it right. This idea of consistency promotes the API market for pharmaceuticals.

Plants vs manufactured products – when plants are better

There are some issues, however, with manufactured products. Just like they can sometimes be more potent than their plant counterparts, sometimes it’s the opposite. Amanita mushrooms are once again a an applicable example. They’re newer to American culture, and don’t have a history of use as a plant. But they’re also hallucinogenic mushrooms (though different from psilocybin, as they work mainly off the compound muscimol). Producers seem generally afraid to create products with full-blown effects, which creates a market of products that don’t do much, even though the mushrooms themselves, do.

In terms of products being too strong, this is also an issue. A newer rise in emergency room visits is connected with very high THC products, which have become the norm. Whereas plants don’t generally have more than 20% THC (although this amount is incredibly inflated from earlier decades), manufactured products boast numbers like 90% THC. This is no longer in the standard realm of today; and its not shocking that more people get sick. Luckily, THC overdoses are not deadly, just uncomfortable.

Another issue is companies adding toxic substances. Not only does weed not need a lot of pesticides or other chemicals, it wasn’t an industry associated with them as a black market. Yet now with mass legal production, we’re suddenly dealing with sprayed weed, and overuse of agricultural chemicals. What once was a clean black market, is now a grossly dirty legal market; yet its the legal market that always brags about testing. Even though those tests back up just how dirty legal production is.

Vape carts include many different chemicals
Vape carts include many different chemicals

And then think about vapes. Weed might be sprayed with chemicals, but it doesn’t have to be. A vape cart doesn’t exist without the addition of some chemicals. Some are used that don’t have to be, like flavoring or colorants. But other things are necessary since its not a standard state for weed to be in, and it has to be preserved for transport. As such, things like stabilizers and preservatives (vitamin e-acetate) come into play. And this is beyond whatever other tinkering a manufacturer might do.

The same can be said for gummies, and other edibles. The US food market is not a pretty place, because regulation allows for tons of dangerous chemicals in food production. Sure, its possible to make a clean cannabis or mushroom edible, just like its possible to grow organic vegetables, or produce clean meat. However, just because something can happen, doesn’t mean it will. Edibles are food products; and liable to have a list of chemical ingredients, that only people with high level science degrees can pronounce.

Final thoughts

The reality is that for some drugs, both a plant option and a manufactured option, exist. It comes down to a buyer’s personal decision as to what is better. If you want the most basic, unadulterated form; the plant is best. But if you need a stronger product, want the convenience of vapes or edibles, need specific dosing, or have more trust in manufactured products; then this is probably the better option. Either way, if its well made/grown, you should definitely catch a buzz.

Hey all! Cool that you’re with us at; a news source in the independent realm, reporting on the most interesting stories in the growing cannabis and hallucinogen worlds. Hang out with us regularly to catch the updates; and get signed up to the Cannadelics Weekly Newsletter; so you’re always up on what’s going down.

Source link

Continue Reading

Deal of the day

In The Spotlight: Amanita Mushroom Caps (Only $99/lb)




This week’s spotlight is on a unique product that everyone is talking about: Amanita Mushroom Caps. These legal psychedelic mushrooms have been used for hundreds of years due to their spiritual and mind-altering effects. Recently, we’ve secured a significant quantity of Amanita caps from a verified supplier, with prices starting as low as $99 per pound.

Amanita Muscaria Caps: The First Legal Psychedelic Product

Finding legal psychedelic products isn’t easy, as most of them are illegal. However, since Muscimol, and Ibotenic acid (the two active compounds found in these mushrooms) are legal in most parts of the world, you can freely order them online. Amanita mushrooms, traditionally used, offer a less hallucinatory and more spiritual experience compared to regular magic mushrooms. Yet, with the right dosage, they can also become highly psychedelic, often accompanied by very vivid dreams in the nights following consumption.

While various Amanita products, such as vapes, gummies, chocolates, and even joints, are available today, it’s Amanita mushroom caps that should be your first choice. Sourcing A-grade mushrooms allows you to create a range of products, from powders and teas to edibles, chocolates, vapes, gummies and joints. This is why, while the sales of gummies and vapes are rising, it’s Amanita caps that most people are seeking.

Purchasing the mushrooms themselves is also very affordable, especially when sourced from reputable suppliers, like the one we’ve verified for you. You can obtain them at an attractive price, even when buying small amounts. If you’re ready to invest a bit more, bulk orders offer a fantastic opportunity to stock up on these premium mushrooms, with prices starting at $99 per pound.

Best Deals On Legal Psychedelic Mushrooms:

Amanita Mushroom Caps

In the realm of holistic wellness, Amanita mushroom caps stand out for their distinctive properties and historical significance. We’re pleased to present an exclusive promotion from verified suppliers.

We offer two deals: a 75% discount on Amanita Muscaria caps, tailored for individuals, groups of friends, and boutique shops keen on introducing Amanita mushrooms to their clientele; and a 50% discount on all bulk and wholesale orders, making it an ideal choice for wholesalers, small to medium-sized businesses, and event organizers.

75% Off Amanita Mushroom Caps

Elevate your psychedelic experience with premium Amanita mushroom caps, now available at an impressive 75% off. For those looking to make an introductory purchase, the 1 OZ option, priced at just $17.5, offers an excellent starting point. However, if you wish to make a more substantial investment, the 1/4 lb option is available at an attractive $62.50.

Choose from a range of quantities tailored to your needs:

  • 1/8 OZ for just $2.75
  • 1/4 OZ at $5.25
  • 1/2 OZ for $10.00
  • 1 OZ at $17.50
  • 1/4 lb for a mere $62.50

For orders of 1 lb and above, check the Bulk Orders section.

How to claim this offer: Simply add your desired items to the cart, and watch as the 75% discount is automatically applied at checkout!

Save Big on Amanita Mushroom Caps

(The 75% discount automatically applies at checkout)

Bulk Amanita Muscaria Mushrooms – Starting from $99/lb

For businesses and enthusiasts seeking the best prices, our bulk orders present an unbeatable proposition, starting at only $99 per pound.

Due to the mushroom’s adaptability, it’s perfectly suited for a variety of applications, from selling mushroom caps to product formulations, including popular gummies. This is your opportunity to invest in a unique legal psychedelic product that the world is only just beginning to embrace.

Source it from a reliable supplier!

Save on Bulk Amanita Muscaria Mushrooms

Subscribe to our weekly newsletter

As always, the best deals on Amanita Muscaria mushrooms and other legal psychedelic products are reserved for our followers. Subscribe below and never be left without your beloved products!

Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media